High Court Rejects ‘After-Arising Technology’ Challenge To Entresto Patent

( December 15, 2025, 2:19 PM EST) -- WASHINGTON, D.C. — The U.S. Supreme Court on Dec. 15 rejected a generic drugmaker’s petition for a writ of certiorari, leaving in place a Federal Circuit U.S. Court of Appeals ruling that a Delaware federal judge erred in holding that claims in a Novartis Pharmaceutical Corp. patent covering the Novartis heart failure drug were not properly enabled....